Regina Salvat is a Principal at Forbion, focusing on private and crossover investment opportunities in the biotech sector from the firms Boston office. She holds a PhD in Protein Engineering from Dartmouth College and previously worked at Sofinnova Investments, where she was involved in several successful investments, including Capstan Therapeutics.
Regina is actively involved with her alma mater, serving on the Deans Council for Dartmouths Thayer School of Engineering. This indicates a commitment to giving back to her academic community and staying connected with the next generation of engineers.
Her PhD research focused on computationally redesigning enzymes to reduce immunogenicity while enhancing their therapeutic activity.
Read the full overview →Unless the value is proven by data, they are unlikely to value fancy features. It is very likely that they will negotiate pricing or other important terms. They prefer to do logical analysis and value evidence over emotions.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.